Aspiro Therapeutics Selected to Present at 2025 Respiratory Innovation Summit
Tucson, Arizona / April 17, 2025 — Aspiro Therapeutics, a biopharmaceutical company dedicated to pioneering the development of groundbreaking treatments for obstructive lung diseases, announced today that it has been selected as a Showcase Company at the 2025 Respiratory Innovation Summit (RIS), hosted by the American Thoracic Society (ATS). Aspiro’s CEO and Co-Founder, James Lovgren, […]